최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of Korean Medicine = 대한한의학회지, v.39 no.1, 2018년, pp.1 - 12
권혁제 (경희대학교 한의과대학) , 김미혜 (경희대학교 한의과대학) , 양웅모 (경희대학교 한의과대학)
Objectives: Astragalus membranaceus has been reported to inhibit immune responses, but its effect on hair loss is not clear. In this study, the effect of A. membranaceus extract (AM) on hair regrowth in C57BL/6 mice with natural hair loss in the telogen phase was investigated. Methods: Mice with nat...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
탈모란 무엇인가? | 모발은 물리적 충격, 자외선, 한랭자극으로부터 신체를 보호하는 역할을 담당하는 피부의 부속기관으로, 1~6년의 성장기(anagen), 1~3주의 퇴행기(catagen), 2~3개월의 휴지기(telogen) 등 3 단계의모주기를 통하여 성장과 탈락을 반복한다1). 탈모는 모낭의 소형화, 휴지기 모낭의 증가, 모발의 길이와 밀도의 감소로 인하여 두피, 액와, 음부 등에 존재하는 모발이 탈락하는 질환이다2),3). | |
Dutasteride의 문제점은 무엇인가? | 또한 두피 내에 존재하는 DHT를 41% 정도 감소시키는 것으로 알려졌으나14), 성욕 감소, 무기력,사정 장애, 우울 등의 부작용이 나타나는 것으로 보고되었다15). Dutasteride는 Finasteride보다 type 2 5α-reductase는 3배, type 1 5α-reductase는 100배 더 강하게 억제하며16), 두피 내 DHT를 51% 가량 감소시키는 것으로 나타났으나14) 사정 장애, 성기능 이상, 무기력, 발기 장애, 여성형 유방 등의 부작용이 확인되어 탈모 치료에 한계가 있다17). Minoxidil은piperidinopyrimidine 계열로 본래 고혈압 치료제였으나 약물 효과 외의 발모 효과가 관찰된 이후, 치료 용도를 탈모치료제로 변경하여 현재까지 사용되고 있다18),19). | |
KGF의 발현 증가로 얻을 수 있는 기대효과는 무엇인가? | 그 외에도 피부, 위장관, 유선 등의 상피세포의 분열과 분화가 KGF에 의해 촉진되는 것으로 알려져 있다62),63). KGF는 피부 내 기저층과 모낭 및 피지선 안의 keratinocyte를 자극하여 성장을 촉진시키고 모발의 성장을 유도한다64). 황기 추출물의 처리는 Hs68 섬유아세포의KGF의 발현을 농도 의존적으로 증가시켰다. |
Stenn KS, Paus R. Controls of Hair Follicle Cycling. Physiological Reviews. 2001;81(1):449-94.
Min BG. Diagnosis and treatment of hair & scalp disorders. Hanmi Book. 2005:21-30.
Zoe DD. Cosmetics in dermatology. 2nd. London: Churchill Livingstone. 1995:179-91.
Ahn SG, Ji HG, Hwang SM, Jung J, Jang KH. Common Skin Disease. Pacific publisher. 2003. 437.
Korean Dermatology Association. Textbook of Dermatology. 6Th. Seoul:Med book. 2014:551-7.
Lee SH, Lee JR. Association of Diffuse Hair loss of Adult Male on Stress, Self-confidence, and Depression. Journal of the Society of Cosmetic Scientists of Korea. 2010;16(4):1171-9.
Fitzpatrick TB, Wolff K. Fitzpatrick?s dermatology in general medicine. 7Th. NewYork:McGraw-Hill. 2008:766-9.
Moustafa AET, Hassan I, Essam AN, Mai SAD. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation. Dermatologic Therapy. 2017;30(1):e12437.
Amin SS, Sachdeva S. Alopecia areata: A review, Saudi Society of Dermatology and Dermatologic Surgery. 2013;17:37-45.
Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. Journal der Deutschen Dermatologischen Gesellschaft. 2011;9(6):51-7.
Varothai S, Bergfeld WF. Androgenetic Alopecia: An Evidence-Based Treatment Update. American Journal of Clinical Dermatology. 2014;15(3):217-30.
Levy LL, Emer JJ. Female pattern alopecia: current perspectives. International Journal of Women's Health. 2013;5:541-56.
Yamana K, Labrie F, Luu-The V. Human type 3 $5{\alpha}$ -reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and Dutasteride. Hormone Molecular Biology and Clinical Investigation. 2010;2:293-9.
Lee SY, Chun SW, Kim JB, No BI. A Case of Combination Therapy with Finasteride and Low Dose Dutasteride in the Treatment of Androgenetic Alopecia. Korean Journal of Dermatology. 2017;55(2):147-8.
Mounsey AL, Reed SW. Diagnosing and treating hair loss. American Family Physician. 2009;80(4):356-62.
Eun HC, Kwon OS, Yeon JH, Skin HS, Kim BY, Ro BI, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study. Journal of the American Academy of Dermatology. 2010;63:252-8.
Choi GS, Kim JH. Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia. Annals of Dermatology. 2016;28(4):444-50.
Lee WS, Ahn HJ, Kim YH. The Effect of Coapplication of Capsaicin and Minoxidil on the Murine Hair growth. Korean Journal of Dermatology. 2003;41(4):451-60.
Zappacosta AR. Reversal of baldness in patient receiving minoxidil for hypertension. The New England Journal of Medicine. 1980;303:1480-1.
Fiedler-Weiss VC. Potential mechanisms of minoxidil-induced hair growth in alopecia areata. Journal of the American Academy of Dermatology. 1987;16:653-6.
Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. British Journal of Dermatology. 2004;150:186-94.
Evelyn YC. Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend?. Journal of the American Association of Nurse Practitioners. 2013;25(8):395-401.
Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update. Part II: treatment, Journal of the American Academy of Dermatology. 2010;62:191-202.
Chiang KS, Mesinkovska NA, Piliang MP, Bergfeld WF. Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients. Journal of Investigative Dermatology Symposium Proceedings. 2015;17:50-5.
Ohtsuki A, Hasegawa T, Komiyama E, Takagi A, Kawasaki J, Ikeda S. 308-nm Excimer Lamp for the Treatment of Alopecia Areata: Clinical Trial on 16 Cases. Indian Journal of Dermatology. 2013;58(4):326.
Munck A, Gavazzoni MF, Trueb RM. Use of low-level laser therapy as monotherapy or concomitant therapy for male and female androgenetic alopecia. Canadian Medical Association Journal. 2013;185(18):1579-85.
Fukuoka H, Suga H. Hair Regeneration Treatment Using Adipose-Derived Stem Cell Conditioned Medium: Follow-up With Trichograms. Eplasty. 2015;15:e10.
Zawar VP, Karad GM. Liquid nitrogen cryotherapy in recalcitrant alopecia areata: a study of 11 patients. International Journal of Trichology. 2016;8:15-20.
Khatu SS, More YE, Gokhale NR, Chavhan DC, Bendsure N. Platelet-rich plasma in androgenic alopecia: myth or an effective tool. Journal of Cutaneous and Aesthetic Surgery. 2014;7(2):107-10.
Lee WG. Sinpyeonsomunjipju. Seoul: Daeseongmunhwasa. 1994:894.
Kwak AC. Hwangjenaegyeong yeongchugyojueoseok. Busan:Iljungsa. 1993:123, 213.
Gal H. Galhongjuhubigeupbang. Beijing:Inminwisaengchulpansa. 1996:196.
So WB. Sossijebyeongwonhuchongnon. Shanghai:Soinchulpansa. 1980:695-6.
Son SM. Bigeupcheongeumyobang. Seoul: Deseongmunhwasa. 1984:434-5.
Jin SG. Oegwajeongjong. Beijing:Inminwisaengchulpansa. 1983:256.
Oh G. Uijonggeumgam. Seoul:Daeseongmunhwasa. 1983:97.
Gao J, Liu H, Xie Y, Zhao H, Xie Z, Zhong Z. Clinical observation of the therapy of catgut embedding and moxibustion on androgenetic alopecia. Modern Journal of Integrated Traditional Chinese and Western Medicine. 2013;22(1):8-15.
Lin KR, Jiang YF, Yu AS. Clinical observation of Chinese comprehensive therapy on androgenetic alopecia of damp and heat in the spleen and the stomach pattern. Shanghai Journal of Traditional Chinese Medicine. 2014;48(8):53-6.
Yang SS. Junguiimsangdaejeon. Seoul: Daeseongchulpansa. 1988:912.
Chen GT. Siryongjungseouigyeolhapjindanchiryohak. Busan:Iljungsa. 1992:1508.
Gu BK. Junguioegwahak. Shanghai:Sanghaegwahakgisulchulpansa. 1985:309-12.
All oriental medicine university bonchohak teacher. Bonchohak. Seoul:Yunglimsa. 2007:576-8.
Bai F, Makino T, Kono K, Nagatsu A, Ono T, Mizukami H. Calycosin and formononetin from astragalus root enhance dimethylarginine dimethylaminohydrolase 2 and nitric oxide synthase expressions in Madin Darby Canine Kidney II cells. Journal of Natural Medicines. 2013;67(4):782-9.
Park CI. Study on Effects of Anti-oxidant and Viscoelastic on Emulsion by the Extract of Astragalus membranaceus. The Korea Journal of Herbology. 2012;27(2):93-7.
Baek NI, Kim YS, Kyung JS, Park KH. Isolation of anti-hepatotoxic agent from the root of Astragalus membranacus. Korean Journal of Pharmacognosy. 1996;27:111-6.
Zang YD, Wang YL, Shen JP, Li DX. Hypotensive and anti-inflammatory effects of Astragalus saponin 1. Acta Pharmacologica Sinica. 1984;19:333-7.
Kim JH, Kim MH, Yang GS, Huh YB, Kim SH, Yang WM. Effects of topical application of Astragalus membranaceus on allergic dermatitis, Immunopharmacology and Immunotoxicology. 2012;35(1):151-6.
Kim MH, Kim SH, Yang WM. Beneficial Effects of Astragaloside IV for Hair Loss via Inhibition of Fas/Fas L-Mediated Apoptotic Signaling. PLoS One. 2014;9(3):e92984.
Paus R, Ito N, Takigawa M, Ito T. The hair follicle and immune privilege. Journal of Investigative Dermatology Symposium Proceedings. 2003;8(2):188-94.
Ansel J, Perry P, Brown J. Cytokine modulation of keratinocyte cytokines. Journal of Investigative Dermatology. 1990;94(6):1015-75.
Whicher JT, Evans SW. Cytokines in disease. Clinical Chemistry. 1990;36:1269-81.
Philpott MP, Sanders DA, Bowen J, Kealey T. Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor- ${\alpha}$ in alopecia areata. British Journal of Dermatology. 1996;135(6):942-8.
Hoffmann R, Eicheler W, Huth A, Wenzel E, Happle R. Cytokines and growth factors influence hair growth in vitro: Possible implications for the pathogenesis and treatment of alopecia areata. Archives of Dermatological Research. 1996;288:153-6.
Gilhar A, Etzioni A, Assy A, Eidelman S. Response of grafts from patients with alopecia areata transplanted onto nude mice, to administration of interferon-gamma. Clinical Immunology and Immunopathology. 1993;66:120-6.
Sato-Kawamura M, Aiba S, Tagami H. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Archives of Dermatological Research. 2003;294(12):536-43.
Freyschmidt-Paul P, McElwee KJ, Hoffmann R, Sundberg JP, Vitacolonna M, Kissling S, et al. Interferon-gamma-deficient mice are resistant to the development of alopecia areata. British Journal of Dermatology. 2006;155(3):515-21.
Teraki Y, Imanishi K, Shiohara T. Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis). Acta Dermato-Venereologica. 1996;76(6):421-3.
Attia EA, El Shennawy D, Sefin A. Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing. Dermatology Research and Practice. 2010;2010:1-6.
Hom DB. Growth factors in wound healing, Otolaryngologic Clinics of North America. 1995;28(5):933-53.
Wemer S, Smola H, Liao X, Longaker MT, Krieg T, Hofschneider PH, et al. The function of KGF in morphogenesis of eithelium and reepithelialization of wounds. Science. 1994;266:819.
Pierce GF, Yanagihara D, Klopchin K, Danilenko DM, Hsu E, Kenney WC, et al. Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. The Journal of Experimental Medicine. 1994;179:831-40.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.